Last updated on December 2006

Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Schizophrenia
  • Age: Between 18 - 65 Years
  • Gender: Male or Female
  • Other:
    schizophrenia all types

You may not be eligible for this study if the following are true:

  • uti
    non organic state
    no depression treatment

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.